Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention

Annals of Oncology

Volumn 20, Issue 7, 2009, Pages 1170-1177

  Han, J W ^a   Kwon, S Y ^a   Won, S C ^a   Shin, Y J ^a   Ko, J H ^a   Lyu, C J ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cancer; Childhood cancer; Late effect; Survivor

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE;

ADOLESCENT; ARTICLE; ASIAN; BONE MARROW DISEASE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; DISEASE SEVERITY; EAR DISEASE; ENDOCRINE DISEASE; EYE DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GROWTH DISORDER; HEART DISEASE; HUMAN; INFANT; KIDNEY DISEASE; LEUKEMIA; LONG TERM CARE; LUNG DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROLOGIC DISEASE; OBESITY; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SKIN DISEASE; SOUTH KOREA; STEM CELL TRANSPLANTATION; THYROID DISEASE;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE OF ONSET; ANTINEOPLASTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CONTINUITY OF PATIENT CARE; ENDOCRINE SYSTEM; FEMALE; FOLLOW-UP STUDIES; HUMANS; KOREA; MALE; NEEDS ASSESSMENT; NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RISK; SURVIVORS; TIME FACTORS; YOUNG ADULT;

EID: 67650360364     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn778     Document Type: Article

References (38)

1. McGregor LM, Metzger ML, Sanders R, Santana VM. Pediatric cancers in the new millennium: Dramatic progress, new challenges. Oncology 2007; 21: 809-420.
2. Meadows AT. Pediatric cancer survivorship: Research and clinical care. J Clin Oncol 2006; 24: 5160-5165.
3. Skinner R, Wallace WH, Levitt GA. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol 2006; 7: 489-498.
4. Oeffinger KC, Mertens AC, Sklar CA et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-1582.
5. Dickerman JD. The late effects of childhood cancer therapy. Pediatrics 2007; 119: 554-568.
6. Bongers ME, Francken AB, Rouwe C et al. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation. Pediatr Blood Cancer 2005; 45: 139-143.
7. Aslett H, Levitt G, Richardson A, Gibson F. A review of long-term follow-up for survivors of childhood cancer. Eur J Cancer 2007; 43: 1781-1790.
8. Landier W, Wallace WH, Hudson MM. Long-term follow-up of pediatric cancer survivors: Education, surveillance, and screening. Pediatr Blood Cancer 2006; 46: 149-158.
9. Blaauwbroek R, Tuinier W, Meyboom-de Jong B et al. Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: A pilot study. Lancet Oncol 2008; 9: 232-238.
10. Eakin EG, Youlden DR, Baade PD et al. Health status of long-term cancer survivors: Results from an Australian population-based sample. Cancer Epidemiol Biomarkers Prev 2006; 15: 1969-1976.
11. Geenen MM, Cardous-Ubbink MC, Kremer LC et al. Medical assessment of adverse health outcomes in long-term survivors-of childhood cancer. JAMA 2007; 297: 2705-2715.
12. Reulen RC, Winter DL, Lancashire ER et al. Health-status of adult survivors of childhood cancer: A large-scale population-based study from the British Childhood Cancer Survivor Study. Int J Cancer 2007; 121: 633-640.
13. Hudson MM, Mertens AC, Yasui Y et al. Health status of adult long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. JAMA 2003; 290: 1583-1592.
14. Childrens Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. http://www.survivorshipguidelines.org/pdf/HR/LTFUGuidelines_HR.pdf (5 April 2008, date last accessed).
15. Skinner R, Wallace WH, Levitt GA. Therapy based LTFU practice statement UKCCSG. http://www.ukccsg.org.uk/public/followup/PracticeStatement/ LTFUfull.pdf (5 April 2008, date last accessed).
16. Scottish Intercollegiate Guidelines Network. Long term follow up of survivors of childhood cancer - a national clinical guideline. http://www.sign.ac.uk/pdf/sign76.pdf (5 April 2008, date last accessed).
17. Arbuckle RB, Huber SL, Zacker C. The consequences of diarrhea occurring during chemotherapy for colorectal cancer: A retrospective study. Oncologist 2000; 5: 250-259.
18. Blazar BR, Weisdorf DJ, Defor T et al. Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Blood 2006; 108: 3216-3222.
19. Stevens MC, Mahler H, Parkes S. The health status of adult survivors of cancer in childhood. Eur J Cancer 1998; 34: 694-698.
20. Hudson MM, Donaldson SS. Treatment of pediatric Hodgkin's lymphoma. Semin Hematol 1999; 36: 313-323.
21. Foreman NK, Faestel PM, Pearson J et al. Health status in 52 long-term survivors of pediatric brain tumors. J Neurooncol 1999; 41: 47-53.
22. Anderson NE. Late complications in childhood central nervous system tumour survivors. Curr Opin Neurol 2003; 16: 677-683.
23. Nandagopal R, Laverdiere C, Mulrooney D et al. Endocrine late effects of childhood cancer therapy: A report from the Children's Oncology Group. Horm Res 2008; 69: 65-74.
24. Johnston K, Vowels M, Carroll S et al. Failure to lactate: A possible late effect of cranial radiation. Pediatr Blood Cancer 2008; 50: 721-722.
25. Stubberfield TG, Byrne GC, Jones TW. Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation. J Pediatr Hematol Oncol 1995; 17: 167-171.
26. Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer 2004; 11: 589-602.
27. Pabla N, Dong Z. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int 2008; 73: 994-1007.
28. Gurney JG, Kadan-Lottick NS, Packer RJ et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003; 97: 663-673.
29. Madanat LM, Lahteenmaki PM, Alin J, Salmi TT. The natural history of thyroid function abnormalities after treatment for childhood cancer. Eur J Cancer 2007; 43: 1161-1170.
30. Webb SM, Badia X. Quality of life in growth hormone deficiency and acromegaly. Endocrinol Metab Clin North Am 2007; 36: 221-232.
31. Blaauwbroek R, Groenier KH, Kamps WA et al. Late effects in adult survivors of childhood cancer: The need for life-long follow-up. Ann Oncol 2007; 18: 1898-1902.
32. Nathan PC, Ness KK, Greenberg ML et al. Health-related quality of life in adult survivors of childhood Wilms tumor or neuroblastoma: A report from the childhood cancer survivor study. Pediatr Blood Cancer 2007; 49: 704-715.
33. Zeltzer LK, Lu Q, Leisenring W et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: A report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 2008; 17: 435-446.
34. Bielack SS, Carrle D, Hardes J et al. Bone tumors in adolescents and young adults. Curr Treat Options Oncol 2008; 9: 67-80.
35. Mosher RB, McCarthy BJ. Late effects in survivors of bone tumors. J Pediatr Oncol Nurs 1998; 15: 72-84.
36. Neglia JP, Friedman DL, Yasui Y et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst 2001; 93: 618-629.
37. Yasuda SU, Zhang L, Huang SM. The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies. Clin Pharmacol Ther 2008; 84: 417-423.
38. Gotay CC, Shimizu H, Muraoka M et al. Health attitudes and behaviors: comparison of Japanese and Americans of Japanese and European Ancestry. Health Place 2004; 10: 153-161.